CIAM
WHWK

Caitong International Asset Management’s Whitehawk Therapeutics WHWK Stock Holding History

Caitong International Asset Management’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$664 Buy
+145
New +$603 ﹤0.01% 1653

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Caitong International Asset Management's WHWK Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Whitehawk Therapeutics (WHWK) in Q2 2026: 145 shares worth $664. The stake represents ﹤0.01% of the portfolio and ranks #1653 among its holdings.

78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Caitong International Asset Management held 145 shares of Whitehawk Therapeutics worth $664 as of Q2 2026.
  • Whitehawk Therapeutics was a new Caitong International Asset Management position in Q2 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1653 holding.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.